| First Author | Miller MM | Year | 2020 |
| Journal | Sci Immunol | Volume | 5 |
| Issue | 43 | PubMed ID | 31924686 |
| Mgi Jnum | J:298158 | Mgi Id | MGI:6469820 |
| Doi | 10.1126/sciimmunol.aay3994 | Citation | Miller MM, et al. (2020) BATF acts as an essential regulator of IL-25-responsive migratory ILC2 cell fate and function. Sci Immunol 5(43) |
| abstractText | A transitory, interleukin-25 (IL-25)-responsive, group 2 innate lymphoid cell (ILC2) subset induced during type 2 inflammation was recently identified as iILC2s. This study focuses on understanding the significance of this population in relation to tissue-resident nILC2s in the lung and intestine. RNA-sequencing and pathway analysis revealed the AP-1 superfamily transcription factor BATF (basic leucine zipper transcription factor, activating transcription factor-like) as a potential modulator of ILC2 cell fate. Infection of BATF-deficient mice with Nippostrongylus brasiliensis showed a selective defect in IL-25-mediated helminth clearance and a corresponding loss of iILC2s in the lung characterized as IL-17RB(high), KLRG1(high), BATF(high), and Arg1(low) BATF deficiency selectively impaired iILC2s because it had no impact on tissue-resident nILC2 frequency or function. Pulmonary-associated iILC2s migrated to the lung after infection, where they represented an early source of IL-4 and IL-13. Although the composition of ILC2s in the small intestine was distinct from those in the lung, their frequency and IL-13 expression remained dependent on BATF, which was also required for optimal goblet and tuft cell hyperplasia. Findings support IL-25-responsive ILC2s as early sentinels of mucosal barrier integrity. |
